CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
Rhea-AI Summary
CB Scientific (OTC PINK:CBSC), a company specializing in non-invasive ambulatory cardiac monitoring products and services, has appointed William "Trip" Thomas as its new Chief Financial Officer, effective October 1, 2024. This appointment follows the resignation of Brooke Turk, who stepped down on September 30, 2024. The company clarified that Turk's departure was not due to any disagreement or conflict.
Mr. Thomas brings a strong educational background to his new role, holding a Bachelor of Science in Accounting from the University of Tampa and a Bachelor of Science in Agribusiness from the University of Florida. Additionally, he is a licensed Certified Public Accountant in the State of Florida, further solidifying his qualifications for the position.
Positive
- Appointment of a new CFO with relevant educational background
- New CFO is a licensed Certified Public Accountant
Negative
- Departure of previous CFO
News Market Reaction
On the day this news was published, CBSC gained 28.71%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
LAS VEGAS, NV / ACCESSWIRE / October 3, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced today that the Company's Board of Directors appointed Mr. William "Trip" Thomas as its Chief Financial Officer effective October 1, 2024. Mr. Thomas is replacing Ms. Brooke Turk who formally tendered her resignation effective September 30, 2024. Ms. Turk's resignation was not the result of any disagreement or conflict with the Company.
Mr. Thomas earned a Bachelor of Science degree in Accounting from the University of Tampa and holds a Bachelor of Science degree in Agribusiness from the University of Florida. He is a licensed Certified Public Account in the State of Florida.
About CB Scientific, Inc.
CB Scientific, Inc., through its international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our electrocardiogram (EKG) devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms provides improved compliance for patients at risk of abnormal heart rhythms, as well as more accurate information for physicians.
Company Contact Information:
Telephone: (888) 225-0870
Email: General Inquiries: info@cbscientificinc.com
Investor Inquiries: investor@cbscientificinc.com
Follow CBSC: X, Facebook, Instagram, LinkedIn, YouTube, and Newsletter
This information disclosure may contain forward-looking statements covered within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions, and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including, without limitation, the ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE: CB Scientific, Inc.
View the original press release on accesswire.com
FAQ
Who is the new CFO of CB Scientific (CBSC)?
What are Trip Thomas's qualifications for the CFO position at CBSC?
When did the previous CFO of CB Scientific (CBSC) resign?
Was there any conflict leading to the previous CFO's resignation from CBSC?
